Supporting partners

Becoming a Supporting Partner of the BACR enables interaction with those working in all fields of cancer research and the opportunity of bringing the attention of Association members and others to your company.

Benefits include:

  • A half-page advert in each issue of the Newsletter
  • a listing in the “Supporting Partners” section of the website with logo and direct link to company website
  • the opportunity to advertise meetings and courses on the BACR website at no additional cost
  • advertise up to 5 jobs per year on the Job Shop page of the website free of charge.

In addition two company individuals are eligible for complimentary membership of the Association.

More details


 

Abcam provides cutting edge antibodies with the most comprehensive and up-to-date datasheets including customer reviews and enquiries, fast delivery, customer service and technical support. In its on-line catalog, Abcam lists more than 57,000 primary antibodies and reagents in all major research areas.

http://www.abcam.com/


AstraZeneca has been generous in its support of BACR activities for many years. This includes the BACR/AstraZeneca Young Scientist Frank Rose Award, first given in 1993 to reward the achievement of a young scientist who had made a significant contribution to cancer research.

In recent years, the Award has been presented at the annual National Cancer Research Institute cancer conference. AstraZeneca continues to support this Award and selected BACR meetings of specific interest. The BACR wishes to express its gratitude to AstraZeneca for its continuing support.

About AstraZeneca

AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare: gastrointestinal, cardiovascular, neuroscience, respiratory, cancer and infection. Backed by strong science and wide-ranging commercial skills, AstraZeneca is committed to the sustainable development of its business and the delivery of a flow of new medicines that bring benefit for patients and add value for wider society.

http://www.astrazeneca.com/


Integrated DNA Technologies (IDT) is the largest supplier of custom-synthesized DNA and RNA in the world, with two manufacturing plants in the U.S. and one in Europe, serving the areas of academic research, biotechnology, and pharmaceutical development

IDT products support applications including DNA sequencing, DNA amplification,expression profiling, microarray analysis, SNP detection, gene quantification, and functional genomics. IDT is unique in its ability to accommodate even the largest orders without compromising quality.

http://www.idtdna.com


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,100 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands.

With two marketed products and an advancing pipeline of promising candidates, we aim to be the next revolutionary force in biotechnology by delivering life-changing products, industry-leading performance, and a tireless commitment to improving patient health.

MedImmune has a drug development portfolio in oncology and its scientists are actively studying multiple aspects of cancer: tumour cell biology, angiogenesis, tumour immunology and the microenvironment, in order to develop novel therapeutics that will improve patient's lives. http://www.medimmune.com/


Mole was founded in June, 2005. The business idea was to make an automated solution for nucleic acid preparation available to all research labs. In February 2008 Mole Genetics launched the GeneMole instrument for the European market. The GeneMole is designed to extract nucleic acids from a wide range of samples and deliver high quality DNA and RNA to an affordable price.

http://www.molegenetics.com


At Roche Applied Science we deliver a broad and growing selection of advanced research tools that accelerate life science discovery. Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cutting-edge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real-time PCR, and cell analysis.

http://www.roche-applied-science.com